TrialThe Journal of infectious diseases2018

Live Respiratory Syncytial Virus (RSV) Vaccine Candidate Containing Stabilized Temperature-Sensitivity Mutations Is Highly Attenuated in RSV-Seronegative Infants and Children.

Ursula J Buchholz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.